Do we need to measure specific antibodies in patients with limbic encephalitis?
- 7 February 2017
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 88 (6) , 508-509
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Characteristics in limbic encephalitis with anti–adenylate kinase 5 autoantibodiesNeurology, 2017
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitisJournal of Neuroimmunology, 2015
- Immunopathology of autoantibody-associated encephalitides: clues for pathogenesisBrain, 2012
- Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitisAnnals of Neurology, 2010
- Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain, 2010
- Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigenThe Lancet Neurology, 2010
- AMPA receptor antibodies in limbic encephalitis alter synaptic receptor locationAnnals of Neurology, 2009
- Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitisJournal of Neuroimmunology, 2007
- Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitisBrain, 2004